A research ward will be established at Shanghai’s First Maternity and Infant Hospital to advance study into reproductive malignancies, congenital deformities, developmental problems, and potentially fatal perinatal illnesses. According to the hospital authorities, the ward will introduce a unique method for a closer link between clinical practise and the creation of new goods and technology through partnerships with pharmaceutical firms.
Related: Federal Food Security Programmes beget better maternal health outcomes
The creation of novel pharmaceuticals and gynaecological endoscopies will be facilitated by a partnership with renowned local pharmaceutical businesses, which was also achieved. This will accelerate the conversion of medical research into tools and medications with therapeutic utility.
Read More from Shine
